Dr. Reddy's Laboratories Limited 2018 Q3 - Results - Earnings Call Slides [Seeking Alpha]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Seeking Alpha
Jan.25.18 | About: Dr. Reddy's (RDY) The following slide deck was published by Dr. Reddy's Laboratories Limited in conjunction with their 2018 Q3 earnings call. 1 13 Click to enlarge Notes: About this article: Expand Tagged: Healthcare , Drug Manufacturers - Other , Earnings Slides , India Want to share your opinion on this article? Add a comment . Disagree with this article? Submit your own . To report a factual error in this article, click here
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Indian shares set to open higher tracking Asian peers [Reuters]Reuters
- Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India [Yahoo! Finance]Yahoo! Finance
- Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in IndiaGlobeNewswire
- Global Freeze Drying Market Size To Exceed USD 10.9 Billion By 2033 | CAGR of 8.55% [Yahoo! Finance]Yahoo! Finance
- Coya Therapeutics GAAP EPS of -$0.79 [Seeking Alpha]Seeking Alpha
RDY
Earnings
- 1/31/24 - Beat
RDY
Sec Filings
- 3/27/24 - Form 6-K
- 3/22/24 - Form 6-K
- 3/22/24 - Form 6-K
- RDY's page on the SEC website